EPHA1 and lung adenocarcinoma: Moderate/high EphA1, A4, A5 and A7 expression was more frequently observed in lung adenocarcinoma patients with ECOG performance status < 2 compared to those with ECOG performance status ≥ 2, at a non significant level (p > 0.05, data not shown).